The ternary complex factor protein ELK1 is an independent prognosticator of disease recurrence in prostate cancer
Author:
Affiliation:
1. Department of Oncology and Barbara Ann Karmanos Cancer Institute Wayne State University Detroit Michigan
Funder
U.S. Department of Defense
Publisher
Wiley
Subject
Urology,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23932
Reference47 articles.
1. Cancer statistics, 2019
2. Targeting Continued Androgen Receptor Signaling in Prostate Cancer
3. Androgen Receptor Rediscovered: The New Biology and Targeting the Androgen Receptor Therapeutically
4. Prostate Cancer Overview
5. Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cancer-associated fibroblast-secreted glucosamine alters the androgen biosynthesis program in prostate cancer via HSD3B1 upregulation;Journal of Clinical Investigation;2023-04-03
2. Comparative analysis of protein expression systems and PTM landscape in the study of transcription factor ELK-1;Protein Expression and Purification;2023-03
3. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain;Molecular Pharmacology;2023-01-31
4. Identification of ELK1 interacting peptide segments in the androgen receptor;Biochemical Journal;2022-07-21
5. ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis;Frontiers in Molecular Biosciences;2021-12-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3